Microbiome testing kit market seen reaching $4.8 billion by 2030

The microbiome testing kit market is projected to grow from $1.63 billion in 2025 to $2.03 billion in 2026, with the pace continuing through 2030. The Business Research Company points to personalized medicine, at-home testing and AI-driven analysis as major demand drivers, with North America leading and Asia-Pacific set for the fastest growth.

Why it matters: - Microbiome testing kits are moving from niche diagnostics toward mainstream wellness and preventive care. - The market’s growth reflects stronger demand for personalized medicine, precision nutrition and health data that can guide lifestyle decisions. - The category’s expansion could shape how consumers, providers and health-tech companies approach digestive health and chronic disease prevention.

What happened: - The Business Research Company released its "Microbiome Testing Kit Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report estimates the market will rise from $1.63 billion in 2025 to $2.03 billion in 2026. - The report projects the market will reach $4.8 billion by 2030. - The report says the market is being tracked across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company offers a free sample of the report. - The company also posted the full market report.

The details: - Microbiome testing kits analyze microbes such as bacteria, viruses and fungi in parts of the body including the gut, skin and oral cavity. - The kits provide information on microbiome composition, health status, nutritional needs and potential disease risks. - The report cites a 24.3% CAGR for 2025 to 2026 and a 24.0% CAGR for 2026 to 2030. - Growth drivers include advances in microbiome research, rising consumer interest in wellness, easier access to DNA sequencing, greater awareness of digestive health and more funding for related studies. - The report points to precision nutrition, AI-powered microbiome data analysis, chronic disease prevention, health-focused e-commerce and personalized healthcare models as additional growth factors. - Expected market trends include more at-home testing, personalized nutrition and wellness insights, broader gut-health applications, preventive screenings and stronger consumer health awareness. - Personalized medicine is a major demand driver because it uses genetic, lifestyle and environmental data to tailor treatment and prevention. - Microbiome testing supports personalized medicine by adding microbial data that can guide targeted health strategies. - The report cites a February 2024 Personalized Medicine Coalition update showing the U.S. Food and Drug Administration approved 26 personalized medicines in 2023, up from 12 in 2022. - The report says North America was the largest market for personalized genomics in 2025 because of advanced healthcare infrastructure and high consumer awareness. - The report says Asia-Pacific is expected to grow fastest during the forecast period because of higher healthcare investment, a larger middle class and more adoption of new health technologies.

Between the lines: - The market’s momentum suggests testing kits are becoming part of a broader shift toward data-driven consumer health. - The emphasis on at-home testing and e-commerce points to a market that is likely to expand beyond clinics into direct-to-consumer channels. - The regional split suggests mature demand in North America and faster adoption potential in emerging Asia-Pacific markets.

What's next: - The report expects growth to stay strong through 2030 as personalized health tools become more common. - More product development is likely around AI analysis, preventive screening and nutrition guidance. - Regional competition may intensify as Asia-Pacific adoption accelerates and North America keeps a lead in scale.